POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 94 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $127,312 | -14.6% | 43,600 | -6.8% | 0.00% | -50.0% |
| Q1 2024 | $149,158 | -5.1% | 46,758 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $157,107 | +41.2% | 46,758 | 0.0% | 0.00% | +100.0% |
| Q3 2023 | $111,284 | +35.2% | 46,758 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $82,294 | -42.9% | 46,758 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $144,015 | -41.9% | 46,758 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $247,817 | +50.2% | 46,758 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $165,000 | +36.4% | 46,758 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $121,000 | -42.1% | 46,758 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $209,000 | -34.3% | 46,758 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $318,000 | -6.7% | 46,758 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $341,000 | -27.3% | 46,758 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $469,000 | +4.9% | 46,758 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $447,000 | – | 46,758 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $11,445,000 | 1.96% |
| Pentwater Capital Management LP | 4,967,227 | $54,490,000 | 0.66% |
| SECTORAL ASSET MANAGEMENT INC | 838,826 | $9,202,000 | 0.65% |
| Vivo Capital, LLC | 926,447 | $10,163,000 | 0.45% |
| Boxer Capital, LLC | 1,251,055 | $13,724,000 | 0.44% |
| Ikarian Capital, LLC | 250,837 | $2,752,000 | 0.12% |
| Perceptive Advisors | 787,745 | $8,642,000 | 0.09% |
| Rock Springs Capital Management LP | 289,754 | $3,179,000 | 0.07% |
| Regent Investment Management LLC | 20,000 | $219,000 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,450,268 | $15,909,000 | 0.04% |